Table 1 Baseline characteristics for the 9116 patients and 12,414 eyes.
From: Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
People | Characteristic | Value |
|---|---|---|
Sex n (%) | Female | 5711 (62.6%) |
Male | 3405 (37.4%) | |
Ethnicity n (%) | White/British/Irish | 6682 (73.3%) |
Asian/Indian/Pakistani/Mixed | 59 (0.6%) | |
African or Afro-Caribbean | 0 (0%) | |
Not recorded or unknown | 2375 (26.1%) | |
Living status n (%) | Independent living | 8578 (94.1%) |
Assisted living | 524 (5.75%) | |
Not recorded or unknown | 14 (0.15%) | |
IMD n (%) | Decile 1 (most deprived) | 1178 (12.9%) |
Decile 2 | 721 (7.9%) | |
Decile 3 | 697 (7.6%) | |
Decile 4 | 803 (8.8%) | |
Decile 5 | 815 (8.9%) | |
Decile 6 | 889 (9.8%) | |
Decile 7 | 1011 (11.1%) | |
Decile 8 | 937 (10.3%) | |
Decile 9 | 888 (9.7%) | |
Decile 10 (least deprived) | 1152 (12.6%) | |
Not available or unknown | 25 (0.3%) | |
Median distance in miles to nearest treatment centre (IQR) | 4.52 (2.68, 8.36) | |
Not recorded or unknown | 32 (0.4%) | |
Eyes | ||
Median age at baseline-years (IQR) | 81.4 (75.3, 86.40) | |
Treated eye status n (%) | First treated eye | 9182 (74.0%) |
Second treated eye | 3232 (26.0%) | |
Any ocular co-morbidity present at baseline n (%) | 3385 (27.3%) | |
Any systemic co-morbidity present at baseline n (%) | 5734 (46.2%) |
